REGN668
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for REGN668, covering 2012-03-14 to 2013-06-17. Get the full timeline:
Most recent: Clinical Trial Update: Ascending Dose Study of the Safety and Tolerability of REGN668(SAR231893) in Normal Healthy Volunteers [Phase 1]